Based on its advanced GEMS platform, we are committed to developing a variety of animal models of autoimmune diseases, covering a wide range of tissue-organ specific and systemic autoimmune diseases. These models simulate the complex pathological processes of human autoimmune diseases through precise gene editing techniques or drug induction methods, and have undergone humanization modifications of important target genes, providing strong support for basic research and drug development.